These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24217699)

  • 1. Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.
    Wagenlehner FM; Münch F; Pilatz A; Bärmann B; Weidner W; Wagenlehner CM; Straubinger M; Blenk H; Pfister W; Kresken M; Naber KG
    Antimicrob Agents Chemother; 2014; 58(2):713-21. PubMed ID: 24217699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
    Straubinger M; Blenk H; Naber KG; Wagenlehner FM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wenzler E; Meyer KM; Bleasdale SC; Sikka M; Mendes RE; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.
    Hof H; Juretschke C
    Infection; 2019 Jun; 47(3):493-495. PubMed ID: 30449013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
    Naber CK; Hammer M; Kinzig-Schippers M; Sauber C; Sörgel F; Bygate EA; Fairless AJ; Machka K; Naber KG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H; Veyries ML; Levacher M; Garnier M; Aymard G; Giroud JP; Rouveix B
    Therapie; 2000; 55(6):691-7. PubMed ID: 11234464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy].
    Palou J; Pigrau C; Molina I; Ledesma JM; Angulo J;
    Med Clin (Barc); 2011 Jan; 136(1):1-7. PubMed ID: 20889171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Naber KG
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3947-9. PubMed ID: 16982785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption.
    Loose M; Naber KG; Shields P; Reinhart H; Wagenlehner FME
    Int J Antimicrob Agents; 2018 Mar; 51(3):422-426. PubMed ID: 29158143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling.
    Shimizu T; Harada K; Manabe S; Tsukamoto T; Ito N; Hikasa Y
    J Med Microbiol; 2017 May; 66(5):616-621. PubMed ID: 28470147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers.
    Wijma RA; Huttner A; van Dun S; Kloezen W; Abbott IJ; Muller AE; Koch BCP; Mouton JW
    Int J Antimicrob Agents; 2019 Oct; 54(4):435-441. PubMed ID: 31382030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Novel 3,4-Dihydroxyphenylalanine-Containing Antimicrobial Polymers for the Prevention of Uropathogen Attachment to Urinary Biomaterials.
    MacPhee RA; Koepsel J; Tailly T; Vangala SK; Brennan L; Cadieux PA; Burton JP; Wattengel C; Razvi H; Dalsin J
    J Endourol; 2019 Jul; 33(7):590-597. PubMed ID: 31140304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].
    Karam D; Amgar A; Bourlioux P
    Pathol Biol (Paris); 1988 May; 36(5):452-5. PubMed ID: 3043342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ; Ling GV; Ruby AL; Jang SS; Johnson DL
    J Am Vet Med Assoc; 1983 Oct; 183(8):863-7. PubMed ID: 6415021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.